Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(38:2e)/PE(38:1p) | KDO | 0.0 | BCG061213A03 | 193 | pmol/1E6 cells |
| - | PE(38:2e)/PE(38:1p) | KDO | 0.0 | BCG061213C03 | 155 | pmol/1E6 cells |
| - | PE(38:2e)/PE(38:1p) | KDO | 0.0 | BCG061213B03 | 160 | pmol/1E6 cells |
| - | PE(38:2e)/PE(38:1p) | KDO | 6.0 | BCG061213B02 | 168 | pmol/1E6 cells |
| - | PE(38:2e)/PE(38:1p) | KDO | 6.0 | BCG061213C02 | 172 | pmol/1E6 cells |
| - | PE(38:2e)/PE(38:1p) | KDO | 6.0 | BCG061213A02 | 130 | pmol/1E6 cells |
| - | PE(38:2e)/PE(38:1p) | KDO | 24.0 | BCG061213C01 | 136 | pmol/1E6 cells |
| - | PE(38:2e)/PE(38:1p) | KDO | 24.0 | BCG061213A01 | 147 | pmol/1E6 cells |
| - | PE(38:2e)/PE(38:1p) | KDO | 24.0 | BCG061213B01 | 224 | pmol/1E6 cells |